We demonstrated that the effects of tumorigenesis mediated by Tollip-OE were largely abolished by negative activation of AKT, as evidenced by decreased ability of proliferation (Figure 5b) and EMT of HCC cells (Figure 5c). The gene discussed is AKT1; the disease is hepatocellular carcinoma.